Abstract
Patients with unresectable bladder carcinoma unresponsive to standard chemotherapy have a short survival, but recent clinical trials of salvage treatment have produced some good results. Changes in the dosage of M-VAC; 5- fluorouracil, α-interferon, and cisplatin; and gallium nitrate show promise.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 775-777 |
| Number of pages | 3 |
| Journal | Urologic Clinics of North America |
| Volume | 19 |
| Issue number | 4 |
| State | Published - 1992 |
ASJC Scopus subject areas
- Urology